For US Residents

For US Residents

Let’s get the word out about meningitis B

We send our kids out into the world, full of hope. And we don't want something like meningitis B getting in their way.

Not an actual group. For illustrative purposes only.

BEXSERO is a vaccine approved for 10- through 25-year-olds to prevent meningococcal group B disease (also known as meningitis B) caused by Neisseria meningitidis bacteria.

BEXSERO may not protect all individuals.

 

Vaccination with BEXSERO can be completed with 2 or 3 doses.

Help protect your teen against meningitis B.
Talk to your healthcare professional about vaccination with BEXSERO.

More than 70% of 17-year-olds in the US had not received any meningitis B vaccines as of 2022

There are different types of meningitis vaccines. While many teens or young adults may have received meningitis vaccination when they were younger, they could be missing vaccination for meningitis B. It’s important to ask your teen's doctor about their meningitis vaccination options.

BEXSERO is a vaccine approved to help prevent meningitis B.

Although meningitis B is uncommon, it can be fatal, sometimes within 24 hours

null

Higher Risk.

16- to 23-year-olds have increased rates of meningitis B

null

Uncommon but can be fatal.

About 1 in 10 people infected with meningitis B will die, sometimes within 24 hours

null

Unpredictable & moves quickly.

Meningitis B usually strikes without warning

Approved Use & Safety Info

Approved Use

Important Safety Information About BEXSERO

Approved Use

BEXSERO is a vaccine approved for 10- through 25-year-olds to prevent meningococcal group B disease (also known as meningitis B) caused by Neisseria meningitidis bacteria.

Important Safety Information About BEXSERO

  • Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
  • The tip cap of the prefilled syringe may or may not be made with natural rubber latex. Natural rubber latex may cause allergic reactions
  • Fainting can happen after getting BEXSERO. Sometimes people who faint can fall and hurt themselves. For this reason, your healthcare provider may ask you to sit or lie down for 15 minutes after receiving BEXSERO
  • BEXSERO may not protect all vaccine recipients
  • Some individuals with weakened immune systems may have reduced immune responses to BEXSERO
  • Individuals with certain complement deficiencies and individuals receiving treatment that inhibits terminal complement activation (for example, eculizumab) are at increased risk for invasive disease caused by Neisseria meningitidis group B even after being vaccinated with BEXSERO
  • The most common side effects are pain, redness or swelling at the injection site; fatigue; headache; nausea; and muscle pain
  • Tell your healthcare provider if you are pregnant, plan to become pregnant, or are breast-feeding
  • Ask your healthcare provider about the risks and benefits of BEXSERO. Only a healthcare provider can decide if BEXSERO is right for you or your child
You are encouraged to report vaccine adverse events to the US Department of Health and Human Services.
Visit www.vaers.hhs.gov to file a report or call 1-800-822-7967. You may also file a report with GSK at gsk.public.reportum.com or 1-888-825-5249.
    GSK Help Center logo

    Explore the GSK Help Center website to find customer service support and contact information.

    Contact Us